Breast and colon cell lines from genetically engineered mice: Novel in vitro models for carcinogenesis and cancer prevention

被引：0
|
作者：
Telang, Nitin [1 ]
Katdare, Meena [1 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
149
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [21] Animal Models of Colorectal Cancer: From Spontaneous to Genetically Engineered Models and Their Applications
    Nascimento-Goncalves, Elisabete
    Mendes, Bruno A. L.
    Silva-Reis, Rita
    Faustino-Rocha, Ana, I
    Gama, Adelina
    Oliveira, Paula A.
    VETERINARY SCIENCES, 2021, 8 (04)
  • [22] Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models
    Varticovski, Lyuba
    Hollingshead, Melinda G.
    Robles, Ana I.
    Wu, Xiaolin
    Cherry, James
    Munroe, David J.
    Lukes, Luanne
    Anver, Miriam R.
    Carter, John P.
    Borgel, Suzanne D.
    Stotler, Howard
    Bonomi, Carrie A.
    Nunez, Nomeli P.
    Hursting, Stephen D.
    Qiao, Wenhui
    Deng, Chuxia X.
    Green, Jeff E.
    Hunter, Kent W.
    Merlino, Glenn
    Steeg, Patricia S.
    Wakefield, Lalage M.
    Barrett, J. Carl
    CLINICAL CANCER RESEARCH, 2007, 13 (07) : 2168 - 2177
  • [23] Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development
    Kuwahara, Yasumichi
    Mora-Blanco, E. Lorena
    Banine, Fatima
    Rogers, Arlin B.
    Fletcher, Christopher
    Sherman, Larry S.
    Roberts, Charles W. M.
    Weissman, Bernard E.
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (12) : 2767 - 2777
  • [24] How inclusive are cell lines in preclinical engineered cancer models?
    Raghavan, Shreya
    DISEASE MODELS & MECHANISMS, 2022, 15 (05)
  • [25] The exploration of novel strategy for treatment of pancreactic cancer using genetically engineered mice
    Tada, Motohisa
    Ijichi, Hideaki
    Miyabayashi, Koji
    Mohri, Dai
    Asaoka, Yoshinari
    Ikenoue, Tsuneo
    Tateishi, Keisuke
    Mikata, Rintarou
    Ishihara, Takeshi
    Kanai, Fumihiko
    Imazeki, Fumio
    Moses, Harold L.
    Omata, Masao
    Yokosuka, Osamu
    CANCER RESEARCH, 2011, 71
  • [26] Possible pitfalls investigating cell death responses in genetically engineered mouse models and derived cell lines
    Manzl, Claudia
    Baumgartner, Florian
    Peintner, Lukas
    Schuler, Fabian
    Villunger, Andreas
    METHODS, 2013, 61 (02) : 130 - 137
  • [27] In vitro myogenic and adipogenic differentiation model of genetically engineered bovine embryonic fibroblast cell lines
    Yin, Jinlong
    Jin, Xun
    Beck, Samuel
    Kang, Dong Ho
    Hong, Zhongshan
    Li, Zhehu
    Jin, Yongcheng
    Zhang, Qiankun
    Choi, Yun-Jaie
    Kim, Sung-Chan
    Kim, Hyunggee
    BIOTECHNOLOGY LETTERS, 2010, 32 (02) : 195 - 202
  • [28] In vitro myogenic and adipogenic differentiation model of genetically engineered bovine embryonic fibroblast cell lines
    Jinlong Yin
    Xun Jin
    Samuel Beck
    Dong Ho Kang
    Zhongshan Hong
    Zhehu Li
    Yongcheng Jin
    Qiankun Zhang
    Yun-Jaie Choi
    Sung-Chan Kim
    Hyunggee Kim
    Biotechnology Letters, 2010, 32 : 195 - 202
  • [29] Erythrina excelsa exhibits estrogenic effects in vivo and in vitro and is cytotoxic on breast and colon cancer cell lines
    Ngueu, Sadrine Tchoukouegno
    Tchoumtchoua, Job
    Njamen, Dieudonne
    Halabalaki, Maria
    Laudenbach-Leschowski, Ute
    Diel, Patrick
    PHARMACEUTICAL BIOLOGY, 2016, 54 (05) : 835 - 844
  • [30] Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy
    Shi, Xiaojing
    Cheng, Qinqin
    Hou, Tianling
    Han, Menglu
    Smbatyan, Goar
    Lang, Julie E.
    Epstein, Alan L.
    Lenz, Heinz-Josef
    Zhang, Yong
    MOLECULAR THERAPY, 2020, 28 (02) : 536 - 547
12345